Elevance Health (NYSE:ELV) Stock Unloaded Rep. Gilbert Ray Cisneros, Jr.

Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of Elevance Health, Inc. (NYSE:ELV). In a filing disclosed on June 06th, the Representative disclosed that they had sold between $1,001 and $15,000 in Elevance Health stock on May 30th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Sold $15,001 – $50,000 in shares of SpringWorks Therapeutics (NASDAQ:SWTX) on 7/1/2025.
• Purchased $1,001 – $15,000 in shares of AppLovin (NASDAQ:APP) on 7/1/2025.
• Sold $1,001 – $15,000 in shares of Amdocs (NASDAQ:DOX) on 6/30/2025.
• Purchased $1,001 – $15,000 in shares of CoStar Group (NASDAQ:CSGP) on 6/30/2025.
• Purchased $15,001 – $50,000 in shares of CoStar Group (NASDAQ:CSGP) on 6/27/2025.
• Purchased $1,001 – $15,000 in shares of Xiaomi (OTCMKTS:XIACF) on 6/27/2025.
• Sold $1,001 – $15,000 in shares of ASML (NASDAQ:ASML) on 6/27/2025.
• Sold $1,001 – $15,000 in shares of Willis Towers Watson Public (NASDAQ:WTW) on 6/26/2025.
• Sold $1,001 – $15,000 in shares of Boston Scientific (NYSE:BSX) on 6/26/2025.
• Sold $1,001 – $15,000 in shares of Liberty Media Corporation – Liberty Formula One Series C (NASDAQ:FWONK) on 6/26/2025.

Elevance Health Stock Performance

Shares of ELV stock traded up $0.99 on Monday, hitting $278.08. 1,034,465 shares of the stock were exchanged, compared to its average volume of 1,670,204. The company has a current ratio of 1.44, a quick ratio of 1.44 and a debt-to-equity ratio of 0.64. The firm has a market capitalization of $62.62 billion, a PE ratio of 11.83, a P/E/G ratio of 0.81 and a beta of 0.60. Elevance Health, Inc. has a one year low of $274.60 and a one year high of $567.26. The firm’s 50 day moving average is $371.52 and its two-hundred day moving average is $396.02.

Elevance Health (NYSE:ELV) last released its quarterly earnings data on Thursday, July 17th. The company reported $8.84 EPS for the quarter, missing analysts’ consensus estimates of $9.30 by ($0.46). Elevance Health had a net margin of 2.83% and a return on equity of 17.59%. The firm had revenue of $49.42 billion during the quarter, compared to the consensus estimate of $48.26 billion. During the same quarter last year, the business posted $10.12 earnings per share. Elevance Health’s revenue was up 14.3% compared to the same quarter last year. Sell-side analysts expect that Elevance Health, Inc. will post 33.96 earnings per share for the current fiscal year.

Elevance Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Wednesday, September 10th will be given a dividend of $1.71 per share. This represents a $6.84 annualized dividend and a dividend yield of 2.46%. The ex-dividend date is Wednesday, September 10th. Elevance Health’s dividend payout ratio is presently 29.11%.

Institutional Trading of Elevance Health

Several large investors have recently made changes to their positions in the company. Vanguard Group Inc. lifted its stake in shares of Elevance Health by 3.1% in the 1st quarter. Vanguard Group Inc. now owns 22,152,108 shares of the company’s stock valued at $9,635,281,000 after purchasing an additional 666,534 shares during the last quarter. Price T Rowe Associates Inc. MD increased its holdings in Elevance Health by 4.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 10,618,062 shares of the company’s stock worth $3,917,004,000 after purchasing an additional 464,137 shares during the period. Wellington Management Group LLP increased its holdings in Elevance Health by 42.5% during the 4th quarter. Wellington Management Group LLP now owns 6,355,532 shares of the company’s stock worth $2,344,556,000 after purchasing an additional 1,893,947 shares during the period. Geode Capital Management LLC boosted its position in shares of Elevance Health by 2.4% during the 4th quarter. Geode Capital Management LLC now owns 4,963,991 shares of the company’s stock worth $1,826,447,000 after acquiring an additional 115,971 shares in the last quarter. Finally, Sanders Capital LLC boosted its position in shares of Elevance Health by 1.7% in the 4th quarter. Sanders Capital LLC now owns 4,686,154 shares of the company’s stock valued at $1,728,722,000 after purchasing an additional 76,896 shares during the period. 89.24% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. UBS Group reissued a “buy” rating and set a $484.00 price target (down from $555.00) on shares of Elevance Health in a research note on Monday, July 14th. Barclays lowered their price objective on Elevance Health from $434.00 to $358.00 and set an “overweight” rating for the company in a research report on Friday. Morgan Stanley cut their price target on shares of Elevance Health from $428.00 to $316.00 and set an “overweight” rating on the stock in a report on Friday. Wells Fargo & Company reduced their price target on Elevance Health from $478.00 to $400.00 and set an “overweight” rating on the stock in a research note on Tuesday, July 15th. Finally, Leerink Partners reaffirmed a “market perform” rating and issued a $310.00 price target (down from $510.00) on shares of Elevance Health in a research note on Friday. Seven analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat, Elevance Health has a consensus rating of “Moderate Buy” and a consensus target price of $435.93.

Insider Buying and Selling

In other news, CFO Mark Kaye sold 4,588 shares of the firm’s stock in a transaction on Thursday, April 24th. The stock was sold at an average price of $424.82, for a total transaction of $1,949,074.16. Following the sale, the chief financial officer owned 18,977 shares in the company, valued at $8,061,809.14. This trade represents a 19.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Gail Boudreaux bought 8,500 shares of Elevance Health stock in a transaction that occurred on Friday, July 18th. The stock was purchased at an average price of $286.94 per share, for a total transaction of $2,438,990.00. Following the acquisition, the chief executive officer directly owned 151,020 shares of the company’s stock, valued at $43,333,678.80. The trade was a 5.96% increase in their position. The disclosure for this purchase can be found here. 0.29% of the stock is currently owned by company insiders.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Elevance Health Company Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.